Patent · US Active

Synthesis of 1,4-diazaspiro[5.5]undecan-3-one

US11708337B2 · kind B2 · utility

1Cited by
4References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 24, 2021
Grant dateJul 25, 2023
Priority date
Expiry dateFeb 24, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/47
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.